Astal Laboratories [ASTALLTD] vs Osia Hyper Retail [OSIAHYPER] Detailed Stock Comparison

Astal Laboratories
BSE
Loading...

Osia Hyper Retail
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Astal Laboratories wins in 10 metrics, Osia Hyper Retail wins in 8 metrics, with 0 ties. Astal Laboratories appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Astal Laboratories | Osia Hyper Retail | Better |
---|---|---|---|
P/E Ratio (TTM) | 11.37 | 8.62 | Osia Hyper Retail |
Price-to-Book Ratio | 2.49 | 0.41 | Osia Hyper Retail |
Debt-to-Equity Ratio | 36.86 | 51.08 | Astal Laboratories |
EV/EBITDA | 7.83 | 4.58 | Osia Hyper Retail |
Profit Margin (TTM) | 14.02% | 1.36% | Astal Laboratories |
Operating Margin (TTM) | 16.56% | 3.27% | Astal Laboratories |
EBITDA Margin (TTM) | 16.56% | 3.27% | Astal Laboratories |
Return on Equity | 30.09% | 6.59% | Astal Laboratories |
Return on Assets (TTM) | 17.86% | 6.01% | Astal Laboratories |
Free Cash Flow (TTM) | $-203.57M | $-38.16M | Osia Hyper Retail |
1-Year Return | 1.78% | -55.94% | Astal Laboratories |
Price-to-Sales Ratio (TTM) | 1.41 | 0.11 | Osia Hyper Retail |
Enterprise Value | $1.01B | $3.55B | Osia Hyper Retail |
EV/Revenue Ratio | 1.59 | 0.25 | Osia Hyper Retail |
Gross Profit Margin (TTM) | 21.79% | 14.45% | Astal Laboratories |
Revenue per Share (TTM) | $65 | $107 | Osia Hyper Retail |
Earnings per Share (Diluted) | $8.04 | $1.42 | Astal Laboratories |
Beta (Stock Volatility) | -0.81 | -0.54 | Astal Laboratories |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Astal Laboratories vs Osia Hyper Retail Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Astal Laboratories | 1.92% | 8.74% | 13.24% | 15.51% | 7.21% | 21.02% |
Osia Hyper Retail | -2.04% | -9.51% | -27.16% | -46.02% | -58.11% | -59.27% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Astal Laboratories | 1.78% | 107.26% | 107.26% | 107.26% | 107.26% | 107.26% |
Osia Hyper Retail | -55.94% | -94.79% | -94.01% | -95.82% | -95.82% | -95.82% |
Performance & Financial Health Analysis: Astal Laboratories vs Osia Hyper Retail
Metric | ASTALLTD | OSIAHYPER |
---|---|---|
Market Information | ||
Market Cap | ₹898.37M | ₹1.63B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 24,421 | 155,018 |
90 Day Avg. Volume | 31,810 | 446,970 |
Last Close | ₹95.18 | ₹11.99 |
52 Week Range | ₹66.72 - ₹131.70 | ₹11.99 - ₹50.45 |
% from 52W High | -27.73% | -76.23% |
All-Time High | ₹131.70 (Sep 09, 2024) | ₹397.00 (Mar 28, 2022) |
% from All-Time High | -27.73% | -96.98% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.90% | 0.10% |
Quarterly Earnings Growth | 9.67% | -0.89% |
Financial Health | ||
Profit Margin (TTM) | 0.14% | 0.01% |
Operating Margin (TTM) | 0.17% | 0.03% |
Return on Equity (TTM) | 0.30% | 0.07% |
Debt to Equity (MRQ) | 36.86 | 51.08 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹36.75 | ₹29.69 |
Cash per Share (MRQ) | ₹1.77 | ₹0.52 |
Operating Cash Flow (TTM) | ₹-125,173,000 | ₹-2,304,815,104 |
Levered Free Cash Flow (TTM) | ₹89.25M | ₹-3,247,588,096 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Astal Laboratories vs Osia Hyper Retail
Metric | ASTALLTD | OSIAHYPER |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 11.37 | 8.62 |
Forward P/E | N/A | N/A |
PEG Ratio | N/A | N/A |
Price to Sales (TTM) | 1.41 | 0.11 |
Price to Book (MRQ) | 2.49 | 0.41 |
Market Capitalization | ||
Market Capitalization | ₹898.37M | ₹1.63B |
Enterprise Value | ₹1.01B | ₹3.55B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.59 | 0.25 |
Enterprise to EBITDA | 7.83 | 4.58 |
Risk & Other Metrics | ||
Beta | -0.81 | -0.54 |
Book Value per Share (MRQ) | ₹36.75 | ₹29.69 |
Financial Statements Comparison: Astal Laboratories vs Osia Hyper Retail
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ASTALLTD | OSIAHYPER |
---|---|---|
Revenue/Sales | ₹234.67M | ₹3.13B |
Cost of Goods Sold | ₹183.53M | ₹2.68B |
Gross Profit | ₹51.14M | ₹451.91M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹40.79M | ₹170.05M |
EBITDA | ₹42.18M | ₹214.47M |
Pre-Tax Income | ₹38.49M | ₹81.48M |
Income Tax | ₹11.04M | ₹34.58M |
Net Income (Profit) | ₹27.45M | ₹46.90M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ASTALLTD | OSIAHYPER |
---|---|---|
Cash & Equivalents | ₹17.30M | ₹437.33M |
Total Current Assets | ₹456.39M | ₹4.63B |
Total Current Liabilities | ₹267.71M | ₹2.16B |
Long-Term Debt | ₹4.56M | ₹229.81M |
Total Shareholders Equity | ₹359.95M | ₹1.99B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | N/A | ₹719.19M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ASTALLTD | OSIAHYPER |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ASTALLTD | OSIAHYPER |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 24,421 | 155,018 |
Average Daily Volume (90 Day) | 31,810 | 446,970 |
Shares Outstanding | 9.83M | 133.12M |
Float Shares | 3.37M | 33.57M |
% Held by Insiders | 0.57% | N/A |
% Held by Institutions | 0.00% | N/A |
Dividend Analysis & Yield Comparison: Astal Laboratories vs Osia Hyper Retail
Metric | ASTALLTD | OSIAHYPER |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |